Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0002044770-26-000002

Director acquired 2,233 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goodrich Katherine Director 2025-12-15 Option exercise +2,233 2,233 D
Derivatives
Goodrich Katherine Director 2025-12-15 Option exercise · Restricted Stock Units −2,233 4,467 D
Loading xslF345X05/wk-form4_1768437158.xml…